What question did this study set out to answer?

To develop an automated computational method that uses gene signatures to define cancer subtypes and identify subtype-specific driver genes.

November 1, 2013BMC BioinformaticsOpen Access

A gene signature based method for identifying subtypes and subtype-specific drivers in cancer with an application to medulloblastoma

View Full Paper

Ask AI

Bookmark

To develop an automated computational method that uses gene signatures to define cancer subtypes and identify subtype-specific driver genes.
Engineered an iterative algorithm that alternates between gene expression clustering and gene signature selection.
Applied a principal component analysis (PCA)-based framework to identify and prioritize subtype-specific cancer drivers.
Tested and validated the approach across multiple high-throughput gene expression and copy number aberration datasets of pediatric medulloblastoma.
The subtyping algorithm consistently converged across multiple independent medulloblastoma datasets, yielding highly reproducible gene expression signatures and copy number landscapes.
Top-ranked driver candidates identified by the PCA-based approach were significantly enriched with known biological pathways characteristic of specific medulloblastoma subtypes.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Computational study demonstrates reproducible tumor subtyping and candidate driver identification in medulloblastoma, indicating gene signatures can define boundaries and prioritize drivers.

Cite This Study

Chen et al. (2013) studied this question.

synapsesocial.com/papers/6a7fa35ab407ef562842222a https://doi.org/10.1186/1471-2105-14-s18-s1

View Full Paper

Ask AI

Bookmark

Implication

Computational study demonstrates reproducible tumor subtyping and candidate driver identification in medulloblastoma, indicating gene signatures can define boundaries and prioritize drivers.

A gene signature based method for identifying subtypes and subtype-specific drivers in cancer with an application to medulloblastoma

Key Points

Discussion

Implication

Cite This Study

A gene signature based method for identifying subtypes and subtype-specific drivers in cancer with an application to medulloblastoma

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider